Please wait a minute...
文章检索
预防医学  2026, Vol. 38 Issue (10): 973-976,983    DOI: 10.19485/j.cnki.issn2096-5087.2026.10.001
  论著 本期目录 | 过刊浏览 | 高级检索 |
超重肥胖或中心性肥胖与高尿酸血症共病对老年人血脂异常的影响
吴梦怡, 胡劲松, 黄霜, 黄渊秀
长沙市疾病预防控制中心(长沙市卫生综合监督执法局),湖南 长沙 410004
Effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly
WU Mengyi, HU Jinsong, HUANG Shuang, HUANG Yuanxiu
Changsha Center for Disease Control and Prevention (Changsha Municipal Bureau of Comprehensive Health Supervision and Law Enforcement), Changsha, Hunan 410004, China
全文: PDF(898 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨超重肥胖或中心性肥胖与高尿酸血症共病对老年人血脂异常的影响,为老年人血脂异常早期识别、高危人群筛查和干预提供依据。方法 基于国家基本公共卫生服务项目,选择长沙市≥65岁老年人为研究对象。通过湖南省基层卫生信息系统收集性别、年龄、体质指数、腰围、总胆固醇、三酰甘油和血尿酸等资料。采用多因素logistic回归模型分析超重肥胖或中心性肥胖与高尿酸血症共病对老年人血脂异常的影响,采用Andersson等编制的Excel表计算超额相对危险度(RERI)、归因百分比(AP)和协同指数(SI)。结果 纳入1 755人,其中男性833人,占47.46%;女性922人,占52.54%。年龄M(QR)为73.00(9.00)岁。超重肥胖597人,占34.02%。中心性肥胖583人,占33.22%。高尿酸血症323例,占18.40%。检出血脂异常663例,检出率为37.78%。多因素logistic回归分析结果显示,超重肥胖(OR=2.734,95%CI:2.207~3.386)、中心性肥胖(OR=2.665,95%CI:2.152~3.301)、高尿酸血症(OR=2.459,95%CI:1.910~3.165)、超重肥胖联合高尿酸血症(OR=5.417,95%CI:3.741~7.843)和中心性肥胖联合高尿酸血症(OR=5.307,95%CI:3.633~7.751)与老年人较高的血脂异常风险存在统计学关联。交互作用分析结果显示,超重肥胖与高尿酸血症对老年人血脂异常的影响存在相加交互作用(RERI=1.568,95%CI:0.371~2.765;AP=0.289,95%CI:0.068~0.510;SI=1.550,95%CI:1.135~2.116);中心性肥胖与高尿酸血症对老年人血脂异常的影响存在相加交互作用(RERI=1.303,95%CI:0.115~2.491;AP=0.246,95%CI:0.022~0.470;SI=1.434,95%CI:1.045~1.968)。结论 超重肥胖或中心性肥胖与高尿酸血症共病对老年人血脂异常的影响存在交互作用,可增加老年人血脂异常风险。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
吴梦怡
胡劲松
黄霜
黄渊秀
关键词 : 血脂异常,  超重肥胖,  中心性肥胖,  高尿酸血症,  交互作用,  老年人    
Abstract:Objective To analyze the effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly, so as to provide evidence for early identification, high-risk population screening and precise intervention of dyslipidemia among the elderly. Methods Based on the National Basic Public Health Service Program, the elderly aged ≥65 years in Changsha City were selected as study participants. Data on gender, age, body mass index, waist circumference, total cholesterol, triglycerides and serum uric acid were collected through the Hunan Provincial Primary Health Information System. A multivariable logistic regression model was used to analyze the effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly. The Excel sheet compiled by Andersson et al. was used to calculate the relative excess risk due to interaction (RERI), the attributable proportion due to interaction (AP) and the synergy index (SI). Results A total of 1 755 participants were included, including 833 males (47.46%) and 922 females (52.54%). The median age was 73.00 (interquartile range, 9.00) years. A total of 597 participants had overweight and obesity (34.02%), 583 had central obesity (33.22%), and 323 had hyperuricemia (18.40%). Dyslipidemia was detected in 663 participants, with a detection rate of 37.78%. Multivariable logistic regression analysis showed that overweight and obesity (OR=2.734, 95%CI: 2.207-3.386), central obesity (OR=2.665, 95%CI: 2.152-3.301), hyperuricemia (OR=2.459, 95%CI: 1.910-3.165), overweight and obesity combined with hyperuricemia (OR=5.417, 95%CI: 3.741-7.843) and central obesity combined with hyperuricemia (OR=5.307, 95%CI: 3.633-7.751) were statistically associated with a higher risk of dyslipidemia among the elderly. Interaction analysis showed that there was an additive interaction between overweight and obesity and hyperuricemia on dyslipidemia among the elderly (RERI=1.568, 95%CI: 0.371-2.765; AP=0.289, 95%CI: 0.068-0.510; SI=1.550, 95%CI: 1.135-2.116), and an additive interaction between central obesity and hyperuricemia on dyslipidemia among the elderly (RERI=1.303, 95%CI: 0.115-2.491; AP=0.246, 95%CI: 0.022-0.470; SI=1.434, 95%CI: 1.045-1.968). Conclusion Interaction effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly were observed and may increase the risk of dyslipidemia.
Key words: dyslipidemia    overweight and obesity    central obesity    hyperuricemia    interaction    the elderly
收稿日期: 2026-07-28      修回日期: 2026-08-27      出版日期: 2026-10-10
中图分类号:  R589  
基金资助:湖南省自然科学基金资助项目(2026JJ82442)
作者简介: 吴梦怡,硕士,主管医师,主要从事慢性病预防与控制工作
通信作者: 黄霜,E-mail:283939918@qq.com   
引用本文:   
吴梦怡, 胡劲松, 黄霜, 黄渊秀. 超重肥胖或中心性肥胖与高尿酸血症共病对老年人血脂异常的影响[J]. 预防医学, 2026, 38(10): 973-976,983.
WU Mengyi, HU Jinsong, HUANG Shuang, HUANG Yuanxiu. Effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly. Preventive Medicine, 2026, 38(10): 973-976,983.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2026.10.001      或      https://www.zjyfyxzz.com/CN/Y2026/V38/I10/973
[1] Pirillo A,Casula M,Olmastroni E,et al.Global epidemiology of dyslipidaemias[J].Nat Rev Cardiol,2021,18(10):689-700.
[2] 国家心血管病中心.中国心血管健康与疾病报告2019[M].北京:科学出版社,2020.
[3] 陈曾丽,蒋运兰,卢宇彤,等.中国老年人血脂异常患病率的Meta分析[J].中国全科医学,2022,25(1):115-121.
[4] 陶寄,盛敏阳,许云峰,等.海宁市居民血脂异常的影响因素分析[J].预防医学,2022,34(8):821-825.
[5] 贾瀚璐,沈天然,李钰,等.老年人体质指数和血脂异常的剂量反应关系研究[J].现代预防医学,2023,50(13):2337-2343.
[6] WS/T 428—2013 成人体重判定[S].
[7] 中华医学会内分泌学分会.高尿酸血症和痛风治疗的中国专家共识[J].中华内分泌代谢杂志,2013,29(11):913-920.
[8] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.血脂异常基层诊疗指南(实践版·2019)[J].中华全科医师杂志,2019,18(5):417-421.
[9] Andersson T,Alfredsson L,Källberg H,et al.Calculating measures of biological interaction[J].Eur J Epidemiol,2005,20(7):575-579.
[10] 王盛书,杨姗姗,李皓炜,等.北京城乡老年人群血脂异常流行状况及其与全因死亡的关联研究[J].中国慢性病预防与控制,2024,32(1):8-14.
[11] 周阳,顾忠凯,杨施黛琳,等.2024年上海市奉贤区某社区≥60岁老年人慢性病及共病检出情况分析[J].江苏卫生保健,2026,28(3):239-241.
[12] 孙静文,赖龙胜,林玉凤,等.厦门市某社区65岁及以上老年人健康体检结果分析[J].中国初级卫生保健,2025,39(10):12-15.
[13] 李秋佳,江秀,谢天.成都市郫都区11万常住老年人血脂异常患病率及影响因素分析[J].现代预防医学,2025,52(11):2107-2112.
[14] 王岩,王应昉,陈凤,等.铁西区老年人血脂异常及影响因素分析[J].预防医学,2020,32(9):920-922.
[15] 赵晶晶,曹亚景,李玫,等.肥胖与高尿酸血症的交互作用对血脂异常患病的影响[J].中国慢性病预防与控制,2023,31(12):922-926.
[16] Nussbaumerova B,Rosolova H.Obesity and dyslipidemia[J].Curr Atheroscler Rep,2023,25(12):947-955.
[17] Choi Y J,Shin H S,Choi H S,et al.Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes[J].Lab Investig,2014,94(10):1114-1125.
[18] Item F,Konrad D.Visceral fat and metabolic inflammation:the portal theory revisited[J].Obes Rev,2012,13(Suppl. 2):30-39.
[19] Ali N.Serum uric acid as a mediator of insulin resistance:molecular mechanisms and metabolic pathways[J/OL].Endocrino Diabet & Metabol,2026,9[2026-08-27].https://doi.org/10.1002/edm2.70163.
[1] 黄文, 祝彩琴, 黄敏钢, 许璐璐, 陈康康, 王柯颖, 陈国江, 陈奇峰. 绍兴市老年人跌倒的现况调查[J]. 预防医学, 2026, 38(9): 875-879.
[2] 郭文燕, 陈国荣, 林海森, 阮晓锋, 郑腾云, 阮峰. 2018—2025年珠海市老年人跌倒伤害特征分析[J]. 预防医学, 2026, 38(9): 940-944.
[3] 袁芳, 张爱平. 江北区居民高血压、糖尿病和血脂异常共病现状及影响因素研究[J]. 预防医学, 2026, 38(8): 815-818,823.
[4] 赵玲慧, 凌洁, 徐漪, 曹敏忆. 嘉兴市社区老年人痴呆现况调查[J]. 预防医学, 2026, 38(7): 671-674.
[5] 马宗康, 叶锦, 樊娇, 蔡美怡, 齐韵菡, 陈凤辉. 老年高血压住院患者主动健康行为的潜在剖面分析[J]. 预防医学, 2026, 38(7): 680-685.
[6] 涂传发, 王心怡, 张幽幽, 朱双, 武姗 综述, 王良友 审校. 中心性肥胖防治研究进展[J]. 预防医学, 2026, 38(7): 686-689.
[7] 梁春朵, 杨鹄嘉, 黄晓凤, 马俊倩, 邓树嵩. 不同性别中老年人超敏C反应蛋白/高密度脂蛋白胆固醇比值与高尿酸血症的关系研究[J]. 预防医学, 2026, 38(7): 717-721.
[8] 江燕, 王荣, 温佳鑫. 基于决策树-马尔可夫模型的南京市老年糖尿病患者肺结核筛查成本效用分析[J]. 预防医学, 2026, 38(6): 545-549.
[9] 谢江, 王雨凤, 张娟, 宋英楠, 罗玲, 陶美伊, 苏晚英. 甘油三酯-葡萄糖-衰弱指数与中老年人糖尿病发病风险的关联研究[J]. 预防医学, 2026, 38(6): 573-577,582.
[10] 胡建功, 张世伟, 游凯, 肖春丽, 赵红叶, 万阳, 王凤双, 彭涛, 孙昕霙. 北京市某区居民高血压、糖尿病和血脂异常共病调查[J]. 预防医学, 2026, 38(6): 614-617,621.
[11] 刘杨, 富小飞, 王远航, 李睿. 嘉兴市老年人流行性感冒疫苗保护效果评价[J]. 预防医学, 2026, 38(5): 508-512.
[12] 张文, 吴成果, 郑登虎, 罗建奎, 罗杰, 孙建, 张理翌, 雷蓉蓉, 廖文平. 南川区老年人群结核分枝杆菌潜伏感染调查[J]. 预防医学, 2026, 38(4): 338-342.
[13] 朱颖, 凌羽晓, 祝惠红. 2014—2023年嘉善县老年肺结核患者就诊延迟和确诊延迟分析[J]. 预防医学, 2026, 38(4): 343-347.
[14] 张曦小雪, 王雪纯, 刘良楹, 武文君, 马玉, 何耀, 刘淼. 老年人认知功能变化轨迹的影响因素分析[J]. 预防医学, 2026, 38(4): 352-356.
[15] 史耀熊, 徐洁, 王筱颖, 胡涛, 方珍. 老年糖尿病患者综合护理联合康复干预效果评价[J]. 预防医学, 2026, 38(4): 410-414.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed